NSE: NEPHROPLUS
NEPHROCARE HEALTH SERV L
Price history
+3.33% over 3M
Performance
52-week range
Position in day range
NEPHROPLUS stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹682.38
RSI (14)
68
Neutral momentum
Volatility (ATR)
3.29%
Moderate
Close streak
1d up
Volume vs 20d avg
1.57x
Unusual activity
From 52W high
-0.57%
Up from 52W low
+71.60%
Green days (20)
8/20
Monthly seasonality
Average monthly move for NEPHROPLUS across the available price history.
Key statistics
Open
747.25
Day high
781.5
Day low
734.05
Prev close
765.35
Volume
3.37 L
Avg vol (20d)
2.14 L
52W high
769.75
52W low
446
NEPHROPLUS quarterly results
All NEPHROPLUS results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹282 cr
+23.7% YoY
Net profit
₹31.97 cr
+34.9% YoY
Operating profit
₹39.34 cr
+40.3% YoY
EPS
₹3.19
+35.0% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹282 cr | ₹39.34 cr | ₹31.97 cr | 14.0% | 11.3% | ₹3.19 | +34.9% | +5.3% |
| Q4 FY262026-03-31 | ₹266 cr | ₹27.92 cr | ₹30.37 cr | 10.5% | 11.4% | ₹3.03 | — | -5.8% |
| Q3 FY262025-12-31 | ₹260 cr | ₹39 cr | ₹32.24 cr | 15.0% | 12.4% | ₹3.43 | — | +440.2% |
| Q2 FY262025-09-30 | ₹244 cr | ₹41.89 cr | -₹9.48 cr | 17.2% | -3.9% | — | — | -140.0% |
| Q1 FY262025-06-30 | ₹228 cr | ₹28.05 cr | ₹23.7 cr | 12.3% | 10.4% | ₹2.36 | — | — |
| TTM (last 4 quarters) | ₹1,051 cr | ₹148 cr | ₹85.11 cr | 14.1% | 8.1% | — | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Nephrocare Health Serv Opens Gap-Down at ₹733.10 — Should Investors Read This as a Trend or a One-Day Move?
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Latest market news
Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter
Coforge (COFORGE) trades at ₹1,846.50, +13.40 (+0.73%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next
Aavas Financiers (AAVAS) trades at ₹1,271.50, -14.60 (-1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
HDFC AMC Edges Lower to ₹2,403.90 — Should Investors Read This as a Trend or a One-Day Move?
HDFC AMC (HDFCAMC) trades at ₹2,403.90, -29.90 (-1.24%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Granules India Hits 52-Week High, Up 1.11% — Should Investors Read This as a Trend or a One-Day Move?
Granules India (GRANULES) trades at ₹909.30, +10.05 (+1.11%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Price and history data from NSE via Upstox. For information only, not investment advice.